nornitrogen mustard has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Bruijn, EA; Momerency, G; Slee, PH; Van Cauwenberghe, K; Van Oosterom, AT | 1 |
| Appler, M; Brundrett, RB; Colvin, M; Fenselau, C; Jardine, I; Kan, MN | 1 |
| Brock, N; Pohl, J; Schneider, B | 1 |
3 other study(ies) available for nornitrogen mustard and Benign Neoplasms
| Article | Year |
|---|---|
The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
Topics: Antineoplastic Agents; Cyclophosphamide; Gas Chromatography-Mass Spectrometry; Humans; Neoplasms; Nitrogen Mustard Compounds; Oxazoles; Oxazolidinones; Phosphoramide Mustards | 1994 |
Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
Topics: Adolescent; Biotransformation; Chromatography, Gas; Cyclophosphamide; Female; Humans; Liver; Male; Mass Spectrometry; Mechlorethamine; Middle Aged; Neoplasms; Nitrogen Mustard Compounds | 1978 |
Basic principles in preclinical cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ifosfamide; Mechlorethamine; Mice; Neoplasms; Nitrogen Mustard Compounds; Rats | 1990 |